Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""McNair C"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł :
Targeting p300/CBP axis in lethal prostate cancer.
Autorzy :
Welti J; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research.
Sharp A; Prostate Cancer Targeted Therapy Group, Institute of Cancer Research.
Brooks N; Translational Science, CellCentric Ltd.
Yuan W; Cancer Biomarkers, Institute of Cancer Research.
McNair C; Cancer Biology, Thomas Jefferson University.
Chand SN; Cancer Biology, Sidney Kimmel Cancer Centre, Thomas Jefferson University.
Pal A; Drug Development Unit, Royal Marsden Hospital.
Figueiredo I; Cancer Biomarkers Team, Institute of Cancer Research.
Riisnaes R; Division of Clinical Studies, Institute of Cancer Research.
Gurel B; Institute of Cancer Research.
Rekowski J; Clinical Trials & Statistics Unit, Institute of Cancer Research.
Bogdan D; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research.
West W; CellCentric Ltd.
Young B; Sygnature Discovery Ltd.
Raja M; Sygnature Discovery Ltd.
Prosser A; Sygnature Discovery Services.
Lane J; Bioscience, Sygnature Discovery Ltd.
Thomson S; Sygnature Discovery Ltd.
Worthington J; Axis Bioservices Limited, Axis Bioservices Limited.
Onions S; Sygnature Discovery Services.
Shannon J; Sygnature Discovery Services.
Paoletta S; Sygnature Discovery Services.
Brown R; Sygnature Discovery Services.
Smyth D; Sygnature Discovery Services.
Harbottle GW; Chemistry, Sygnature Discovery Services.
Gil VS; Clinical Studies, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.
Miranda S; Division of Clinical Studies, Institute of Cancer Research.
Crespo M; Section of Medicine, Institute of Cancer Research.
Ferreira A; Cancer Research UK Cancer Therapeutics Unit, Institute of Cancer Research.
Pereira R; Clinical Studies, Institute of Cancer Reseach.
Tunariu N; Radiology Department, The Royal Marsden Hospital & The Institute of Cancer Research.
Carreira S; Division of Clinical Studies, Institute of Cancer Research.
Neeb AJ; Clinical Studies/Cancer Biomarkers, Institute of Cancer Research.
Ning J; The Tumour Profiling Unit, Institute of Cancer Research.
Swain A; Institute of Cancer Research.
Taddei D; Chemistry, Sygnature Discovery Ltd.
International Dream Team SUTC; University of Michigan Medical School.
Schiewer MJ; Cancer Biology, Sidney Kimmel Cancer Center at Jefferson.
Knudsen KE; Depts of Cancer Biology, Urology, Medical Oncology, and Radiation Oncology, Sidney Kimmel Cancer Center at Jefferson Health.
Pegg N; R&D, CellCentric Ltd.
de Bono JS; Institute of Cancer Research .
Pokaż więcej
Źródło :
Cancer discovery [Cancer Discov] 2021 Jan 11. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA Repair.
Autorzy :
McCann JJ; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Vasilevskaya IA; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Poudel Neupane N; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Shafi AA; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
McNair C; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Dylgjeri E; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Mandigo AC; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Schiewer MJ; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Schrecengost RS; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Gallagher P; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Stanek TJ; Department of Biochemistry & Molecular Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
McMahon SB; Department of Biochemistry & Molecular Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Berman-Booty LD; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Ostrander WF Jr; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania.
Knudsen KE; Department of Cancer Biology, Sidney Kimmel Medical College, Philadelphia, Pennsylvania. .
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Feb 01; Vol. 80 (3), pp. 430-443. Date of Electronic Publication: 2019 Nov 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Proliferation*
DNA Repair*
Gene Expression Regulation, Neoplastic*
Carcinogenesis/*pathology
DNA Repair Enzymes/*metabolism
Prostatic Neoplasms/*pathology
Ubiquitin Thiolesterase/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Carcinogenesis/genetics ; Carcinogenesis/metabolism ; DNA Damage ; DNA Repair Enzymes/genetics ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Prognosis ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Tumor Cells, Cultured ; Ubiquitin Thiolesterase/genetics ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
RB Loss Promotes Prostate Cancer Metastasis.
Autorzy :
Thangavel C; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Boopathi E; Sidney Kimmel Center for Translation Medicine, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Liu Y; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Haber A; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Ertel A; Cancer Genomics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Sidney Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Bhardwaj A; Department of Biochemistry and Molecular Biology, X-ray Crystallography and Molecular Interactions, Sidney Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Addya S; Cancer Genomics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Sidney Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Williams N; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Ciment SJ; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Cotzia P; Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Dean JL; Department of Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Snook A; Department of Pharmacology & Experimental Therapeutics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
McNair C; Department of Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Price M; Department of Laboratory of Medicine and Pathology, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota.
Hernandez JR; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland.
Zhao SG; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Birbe R; Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
McCarthy JB; Department of Laboratory of Medicine and Pathology, University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota.
Turley EA; London Health Sciences Center, Departments of Oncology, Biochemistry and Surgery, Schulich School of Medicine, Western University, London, Ontario, Canada.
Pienta KJ; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland.
Feng FY; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan.
Dicker AP; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Sidney Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Knudsen KE; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Sidney Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Urology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Den RB; Department of Radiation Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. .; Sidney Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Cancer Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.; Department of Urology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2017 Feb 15; Vol. 77 (4), pp. 982-995. Date of Electronic Publication: 2016 Dec 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Prostatic Neoplasms/*pathology
Retinoblastoma Protein/*physiology
Actins/metabolism ; Animals ; Cell Line, Tumor ; Cyclin-Dependent Kinase 4/antagonists & inhibitors ; Cyclin-Dependent Kinase 6/antagonists & inhibitors ; E2F Transcription Factors/physiology ; Extracellular Matrix Proteins/antagonists & inhibitors ; Extracellular Matrix Proteins/genetics ; Extracellular Matrix Proteins/physiology ; Humans ; Hyaluronan Receptors/genetics ; Hyaluronan Receptors/physiology ; Male ; Mice ; Neoplasm Metastasis ; Signal Transduction/physiology ; rho-Associated Kinases/physiology
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies